MedTrace Logo

Autologous Chondrocyte Transplantation For Articular Cartilage Regeneration

NCT01503970 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2017-04-12

No results posted yet for this study

Summary

The purpose of this study is to assess safety and efficacy of autologous chondrocyte implantation delivered arthroscopically into chondral lesions of the knee using clinical, biochemical, and MRI outcomes.

Conditions

  • Tear; Knee, Cartilage, Articular

Interventions

DEVICE

Arthroscopic matrix encapsulated chondrocyte implantation

Each implant of collagen scaffold contains approximately 6,000,000 autologous chondrocytes. This constructs of 10 mm diameter are implanted arthroscopically at the defect.

Sponsors & Collaborators

  • National Council of Science and Technology, Mexico

    collaborator OTHER

  • Instituto Nacional de Rehabilitacion

    lead OTHER_GOV

Principal Investigators

  • Clemente Ibarra, M.D. · INR

  • Luis Guillermo Ibarra, M.D. · INR

  • Aldo F Izaguirre, M.D. · INR

  • Enrique Villalobos, M.D. · INR

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2011-12-31
Completion
2012-12-31

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01503970 on ClinicalTrials.gov